Global Buclizine Market Growth 2023-2029

February 2023 | 103 pages | ID: G5DB79B21A44EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Buclizine is an antihistamine and anticholinergic of the diphenylmethylpiperazine group. It is considered to be an antiemetic, similar to meclizine.

LPI (LP Information)' newest research report, the “Buclizine Industry Forecast” looks at past sales and reviews total world Buclizine sales in 2022, providing a comprehensive analysis by region and market sector of projected Buclizine sales for 2023 through 2029. With Buclizine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Buclizine industry.

This Insight Report provides a comprehensive analysis of the global Buclizine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Buclizine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Buclizine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Buclizine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Buclizine.

The global Buclizine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Buclizine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Buclizine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Buclizine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Buclizine players cover Stuart Pharmaceuticals, Laboratorios Rocnarf, UCB, Mankind Pharma, Johnson and Johnson, Meider Pharma, Sanofi, MK Pharma and HUA Shin Chemical Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Buclizine market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Hospital
• Drug Store

Segmentation by application

• Antiallergic Agent
• Histamine H?-Receptor Antagonist

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Stuart Pharmaceuticals
• Laboratorios Rocnarf
• UCB
• Mankind Pharma
• Johnson and Johnson
• Meider Pharma
• Sanofi
• MK Pharma
• HUA Shin Chemical Pharmaceutical
• Peili Pharmaceutical
• Pfizer
• Sinphar
• Al Pharm

Key Questions Addressed in this Report

What is the 10-year outlook for the global Buclizine market?

What factors are driving Buclizine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Buclizine market opportunities vary by end market size?

How does Buclizine break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Buclizine Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Buclizine by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Buclizine by Country/Region, 2018, 2022 & 2029
2.2 Buclizine Segment by Type
  2.2.1 Hospital
  2.2.2 Drug Store
2.3 Buclizine Sales by Type
  2.3.1 Global Buclizine Sales Market Share by Type (2018-2023)
  2.3.2 Global Buclizine Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Buclizine Sale Price by Type (2018-2023)
2.4 Buclizine Segment by Application
  2.4.1 Antiallergic Agent
  2.4.2 Histamine H?-Receptor Antagonist
2.5 Buclizine Sales by Application
  2.5.1 Global Buclizine Sale Market Share by Application (2018-2023)
  2.5.2 Global Buclizine Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Buclizine Sale Price by Application (2018-2023)

3 GLOBAL BUCLIZINE BY COMPANY

3.1 Global Buclizine Breakdown Data by Company
  3.1.1 Global Buclizine Annual Sales by Company (2018-2023)
  3.1.2 Global Buclizine Sales Market Share by Company (2018-2023)
3.2 Global Buclizine Annual Revenue by Company (2018-2023)
  3.2.1 Global Buclizine Revenue by Company (2018-2023)
  3.2.2 Global Buclizine Revenue Market Share by Company (2018-2023)
3.3 Global Buclizine Sale Price by Company
3.4 Key Manufacturers Buclizine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Buclizine Product Location Distribution
  3.4.2 Players Buclizine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR BUCLIZINE BY GEOGRAPHIC REGION

4.1 World Historic Buclizine Market Size by Geographic Region (2018-2023)
  4.1.1 Global Buclizine Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Buclizine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Buclizine Market Size by Country/Region (2018-2023)
  4.2.1 Global Buclizine Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Buclizine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Buclizine Sales Growth
4.4 APAC Buclizine Sales Growth
4.5 Europe Buclizine Sales Growth
4.6 Middle East & Africa Buclizine Sales Growth

5 AMERICAS

5.1 Americas Buclizine Sales by Country
  5.1.1 Americas Buclizine Sales by Country (2018-2023)
  5.1.2 Americas Buclizine Revenue by Country (2018-2023)
5.2 Americas Buclizine Sales by Type
5.3 Americas Buclizine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Buclizine Sales by Region
  6.1.1 APAC Buclizine Sales by Region (2018-2023)
  6.1.2 APAC Buclizine Revenue by Region (2018-2023)
6.2 APAC Buclizine Sales by Type
6.3 APAC Buclizine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Buclizine by Country
  7.1.1 Europe Buclizine Sales by Country (2018-2023)
  7.1.2 Europe Buclizine Revenue by Country (2018-2023)
7.2 Europe Buclizine Sales by Type
7.3 Europe Buclizine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Buclizine by Country
  8.1.1 Middle East & Africa Buclizine Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Buclizine Revenue by Country (2018-2023)
8.2 Middle East & Africa Buclizine Sales by Type
8.3 Middle East & Africa Buclizine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Buclizine
10.3 Manufacturing Process Analysis of Buclizine
10.4 Industry Chain Structure of Buclizine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Buclizine Distributors
11.3 Buclizine Customer

12 WORLD FORECAST REVIEW FOR BUCLIZINE BY GEOGRAPHIC REGION

12.1 Global Buclizine Market Size Forecast by Region
  12.1.1 Global Buclizine Forecast by Region (2024-2029)
  12.1.2 Global Buclizine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Buclizine Forecast by Type
12.7 Global Buclizine Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Stuart Pharmaceuticals
  13.1.1 Stuart Pharmaceuticals Company Information
  13.1.2 Stuart Pharmaceuticals Buclizine Product Portfolios and Specifications
  13.1.3 Stuart Pharmaceuticals Buclizine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Stuart Pharmaceuticals Main Business Overview
  13.1.5 Stuart Pharmaceuticals Latest Developments
13.2 Laboratorios Rocnarf
  13.2.1 Laboratorios Rocnarf Company Information
  13.2.2 Laboratorios Rocnarf Buclizine Product Portfolios and Specifications
  13.2.3 Laboratorios Rocnarf Buclizine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Laboratorios Rocnarf Main Business Overview
  13.2.5 Laboratorios Rocnarf Latest Developments
13.3 UCB
  13.3.1 UCB Company Information
  13.3.2 UCB Buclizine Product Portfolios and Specifications
  13.3.3 UCB Buclizine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 UCB Main Business Overview
  13.3.5 UCB Latest Developments
13.4 Mankind Pharma
  13.4.1 Mankind Pharma Company Information
  13.4.2 Mankind Pharma Buclizine Product Portfolios and Specifications
  13.4.3 Mankind Pharma Buclizine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Mankind Pharma Main Business Overview
  13.4.5 Mankind Pharma Latest Developments
13.5 Johnson and Johnson
  13.5.1 Johnson and Johnson Company Information
  13.5.2 Johnson and Johnson Buclizine Product Portfolios and Specifications
  13.5.3 Johnson and Johnson Buclizine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Johnson and Johnson Main Business Overview
  13.5.5 Johnson and Johnson Latest Developments
13.6 Meider Pharma
  13.6.1 Meider Pharma Company Information
  13.6.2 Meider Pharma Buclizine Product Portfolios and Specifications
  13.6.3 Meider Pharma Buclizine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Meider Pharma Main Business Overview
  13.6.5 Meider Pharma Latest Developments
13.7 Sanofi
  13.7.1 Sanofi Company Information
  13.7.2 Sanofi Buclizine Product Portfolios and Specifications
  13.7.3 Sanofi Buclizine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Sanofi Main Business Overview
  13.7.5 Sanofi Latest Developments
13.8 MK Pharma
  13.8.1 MK Pharma Company Information
  13.8.2 MK Pharma Buclizine Product Portfolios and Specifications
  13.8.3 MK Pharma Buclizine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 MK Pharma Main Business Overview
  13.8.5 MK Pharma Latest Developments
13.9 HUA Shin Chemical Pharmaceutical
  13.9.1 HUA Shin Chemical Pharmaceutical Company Information
  13.9.2 HUA Shin Chemical Pharmaceutical Buclizine Product Portfolios and Specifications
  13.9.3 HUA Shin Chemical Pharmaceutical Buclizine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 HUA Shin Chemical Pharmaceutical Main Business Overview
  13.9.5 HUA Shin Chemical Pharmaceutical Latest Developments
13.10 Peili Pharmaceutical
  13.10.1 Peili Pharmaceutical Company Information
  13.10.2 Peili Pharmaceutical Buclizine Product Portfolios and Specifications
  13.10.3 Peili Pharmaceutical Buclizine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Peili Pharmaceutical Main Business Overview
  13.10.5 Peili Pharmaceutical Latest Developments
13.11 Pfizer
  13.11.1 Pfizer Company Information
  13.11.2 Pfizer Buclizine Product Portfolios and Specifications
  13.11.3 Pfizer Buclizine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Pfizer Main Business Overview
  13.11.5 Pfizer Latest Developments
13.12 Sinphar
  13.12.1 Sinphar Company Information
  13.12.2 Sinphar Buclizine Product Portfolios and Specifications
  13.12.3 Sinphar Buclizine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Sinphar Main Business Overview
  13.12.5 Sinphar Latest Developments
13.13 Al Pharm
  13.13.1 Al Pharm Company Information
  13.13.2 Al Pharm Buclizine Product Portfolios and Specifications
  13.13.3 Al Pharm Buclizine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Al Pharm Main Business Overview
  13.13.5 Al Pharm Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Buclizine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Buclizine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Hospital
Table 4. Major Players of Drug Store
Table 5. Global Buclizine Sales by Type (2018-2023) & (K Units)
Table 6. Global Buclizine Sales Market Share by Type (2018-2023)
Table 7. Global Buclizine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Buclizine Revenue Market Share by Type (2018-2023)
Table 9. Global Buclizine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Buclizine Sales by Application (2018-2023) & (K Units)
Table 11. Global Buclizine Sales Market Share by Application (2018-2023)
Table 12. Global Buclizine Revenue by Application (2018-2023)
Table 13. Global Buclizine Revenue Market Share by Application (2018-2023)
Table 14. Global Buclizine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Buclizine Sales by Company (2018-2023) & (K Units)
Table 16. Global Buclizine Sales Market Share by Company (2018-2023)
Table 17. Global Buclizine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Buclizine Revenue Market Share by Company (2018-2023)
Table 19. Global Buclizine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Buclizine Producing Area Distribution and Sales Area
Table 21. Players Buclizine Products Offered
Table 22. Buclizine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Buclizine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Buclizine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Buclizine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Buclizine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Buclizine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Buclizine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Buclizine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Buclizine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Buclizine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Buclizine Sales Market Share by Country (2018-2023)
Table 35. Americas Buclizine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Buclizine Revenue Market Share by Country (2018-2023)
Table 37. Americas Buclizine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Buclizine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Buclizine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Buclizine Sales Market Share by Region (2018-2023)
Table 41. APAC Buclizine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Buclizine Revenue Market Share by Region (2018-2023)
Table 43. APAC Buclizine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Buclizine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Buclizine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Buclizine Sales Market Share by Country (2018-2023)
Table 47. Europe Buclizine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Buclizine Revenue Market Share by Country (2018-2023)
Table 49. Europe Buclizine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Buclizine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Buclizine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Buclizine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Buclizine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Buclizine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Buclizine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Buclizine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Buclizine
Table 58. Key Market Challenges & Risks of Buclizine
Table 59. Key Industry Trends of Buclizine
Table 60. Buclizine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Buclizine Distributors List
Table 63. Buclizine Customer List
Table 64. Global Buclizine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Buclizine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Buclizine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Buclizine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Buclizine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Buclizine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Buclizine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Buclizine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Buclizine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Buclizine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Buclizine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Buclizine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Buclizine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Buclizine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Stuart Pharmaceuticals Basic Information, Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 79. Stuart Pharmaceuticals Buclizine Product Portfolios and Specifications
Table 80. Stuart Pharmaceuticals Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Stuart Pharmaceuticals Main Business
Table 82. Stuart Pharmaceuticals Latest Developments
Table 83. Laboratorios Rocnarf Basic Information, Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 84. Laboratorios Rocnarf Buclizine Product Portfolios and Specifications
Table 85. Laboratorios Rocnarf Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Laboratorios Rocnarf Main Business
Table 87. Laboratorios Rocnarf Latest Developments
Table 88. UCB Basic Information, Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 89. UCB Buclizine Product Portfolios and Specifications
Table 90. UCB Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. UCB Main Business
Table 92. UCB Latest Developments
Table 93. Mankind Pharma Basic Information, Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 94. Mankind Pharma Buclizine Product Portfolios and Specifications
Table 95. Mankind Pharma Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Mankind Pharma Main Business
Table 97. Mankind Pharma Latest Developments
Table 98. Johnson and Johnson Basic Information, Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 99. Johnson and Johnson Buclizine Product Portfolios and Specifications
Table 100. Johnson and Johnson Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Johnson and Johnson Main Business
Table 102. Johnson and Johnson Latest Developments
Table 103. Meider Pharma Basic Information, Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 104. Meider Pharma Buclizine Product Portfolios and Specifications
Table 105. Meider Pharma Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Meider Pharma Main Business
Table 107. Meider Pharma Latest Developments
Table 108. Sanofi Basic Information, Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi Buclizine Product Portfolios and Specifications
Table 110. Sanofi Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Sanofi Main Business
Table 112. Sanofi Latest Developments
Table 113. MK Pharma Basic Information, Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 114. MK Pharma Buclizine Product Portfolios and Specifications
Table 115. MK Pharma Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. MK Pharma Main Business
Table 117. MK Pharma Latest Developments
Table 118. HUA Shin Chemical Pharmaceutical Basic Information, Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 119. HUA Shin Chemical Pharmaceutical Buclizine Product Portfolios and Specifications
Table 120. HUA Shin Chemical Pharmaceutical Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. HUA Shin Chemical Pharmaceutical Main Business
Table 122. HUA Shin Chemical Pharmaceutical Latest Developments
Table 123. Peili Pharmaceutical Basic Information, Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 124. Peili Pharmaceutical Buclizine Product Portfolios and Specifications
Table 125. Peili Pharmaceutical Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Peili Pharmaceutical Main Business
Table 127. Peili Pharmaceutical Latest Developments
Table 128. Pfizer Basic Information, Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 129. Pfizer Buclizine Product Portfolios and Specifications
Table 130. Pfizer Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Pfizer Main Business
Table 132. Pfizer Latest Developments
Table 133. Sinphar Basic Information, Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 134. Sinphar Buclizine Product Portfolios and Specifications
Table 135. Sinphar Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Sinphar Main Business
Table 137. Sinphar Latest Developments
Table 138. Al Pharm Basic Information, Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 139. Al Pharm Buclizine Product Portfolios and Specifications
Table 140. Al Pharm Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Al Pharm Main Business
Table 142. Al Pharm Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Buclizine
Figure 2. Buclizine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Buclizine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Buclizine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Buclizine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Hospital
Figure 10. Product Picture of Drug Store
Figure 11. Global Buclizine Sales Market Share by Type in 2022
Figure 12. Global Buclizine Revenue Market Share by Type (2018-2023)
Figure 13. Buclizine Consumed in Antiallergic Agent
Figure 14. Global Buclizine Market: Antiallergic Agent (2018-2023) & (K Units)
Figure 15. Buclizine Consumed in Histamine H?-Receptor Antagonist
Figure 16. Global Buclizine Market: Histamine H?-Receptor Antagonist (2018-2023) & (K Units)
Figure 17. Global Buclizine Sales Market Share by Application (2022)
Figure 18. Global Buclizine Revenue Market Share by Application in 2022
Figure 19. Buclizine Sales Market by Company in 2022 (K Units)
Figure 20. Global Buclizine Sales Market Share by Company in 2022
Figure 21. Buclizine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Buclizine Revenue Market Share by Company in 2022
Figure 23. Global Buclizine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Buclizine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Buclizine Sales 2018-2023 (K Units)
Figure 26. Americas Buclizine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Buclizine Sales 2018-2023 (K Units)
Figure 28. APAC Buclizine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Buclizine Sales 2018-2023 (K Units)
Figure 30. Europe Buclizine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Buclizine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Buclizine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Buclizine Sales Market Share by Country in 2022
Figure 34. Americas Buclizine Revenue Market Share by Country in 2022
Figure 35. Americas Buclizine Sales Market Share by Type (2018-2023)
Figure 36. Americas Buclizine Sales Market Share by Application (2018-2023)
Figure 37. United States Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Buclizine Sales Market Share by Region in 2022
Figure 42. APAC Buclizine Revenue Market Share by Regions in 2022
Figure 43. APAC Buclizine Sales Market Share by Type (2018-2023)
Figure 44. APAC Buclizine Sales Market Share by Application (2018-2023)
Figure 45. China Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Buclizine Sales Market Share by Country in 2022
Figure 53. Europe Buclizine Revenue Market Share by Country in 2022
Figure 54. Europe Buclizine Sales Market Share by Type (2018-2023)
Figure 55. Europe Buclizine Sales Market Share by Application (2018-2023)
Figure 56. Germany Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Buclizine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Buclizine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Buclizine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Buclizine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Buclizine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Buclizine in 2022
Figure 71. Manufacturing Process Analysis of Buclizine
Figure 72. Industry Chain Structure of Buclizine
Figure 73. Channels of Distribution
Figure 74. Global Buclizine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Buclizine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Buclizine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Buclizine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Buclizine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Buclizine Revenue Market Share Forecast by Application (2024-2029)